학술논문
SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis
Document Type
Article
Author
Source
In: Molecular Cancer . (Molecular Cancer, December 2023, 22(1))
Subject
Language
English
ISSN
14764598